BioMarin Clinical Trial Program Update for Duchenne Muscular Dystrophy

April 23, 2024

On Tuesday, April 23, 2024, BioMarin Pharmaceuticals shared a Clinical Trial program update for the Duchenne community, including what they have been working on and a breakdown of study details.

View their community update by clicking here.